Quality & Compliance

Compliance is built in, not added on.

Quality, traceability, and responsible supply-chain practices are foundational to how Kalder Pharmaceuticals is being developed — not features added after the business is running.

Our Philosophy

Responsible pharmaceutical distribution.

Pharmaceutical distribution carries real responsibility. Every product we handle is intended to be used by a patient — and the integrity of the supply chain directly affects patient safety.

Kalder Pharmaceuticals approaches compliance not as a bureaucratic obligation but as the foundation of a trustworthy business. We are building documented processes, qualified partner networks, and technology-backed traceability from the start — not retrofitting compliance onto an existing operation.

Our goal is to be a distributor that suppliers, customers, and regulators can rely on because we have built the right infrastructure — not just because we say the right things.

Quality Commitments

  • Quality before speed
  • Compliance before convenience
  • Traceability at every step
  • No unqualified trading partners
  • Documented procedures for every critical workflow
  • Technology-backed audit trails
  • Proactive, not reactive, compliance management

Core Practices

How we put quality into practice.

Qualified Trading Partners

Every supplier and customer relationship begins with formal qualification — verifying licensing, authorization, and business legitimacy before any transaction occurs.

Product Traceability

Lot-level tracking from supplier receipt through customer delivery, aligned with Drug Supply Chain Security Act (DSCSA) requirements and our internal standards.

Documented Procedures

Written standard operating procedures govern critical workflows — from purchase orders to returns, recalls, and customer onboarding. We do not rely on informal practice.

Product Integrity Protection

Products are handled, stored, and transported by qualified partners under conditions that protect pharmaceutical quality, safety, and efficacy.

Suspect and Illegitimate Product Handling

Clear procedures govern how suspect, illegitimate, or compromised products are identified, quarantined, investigated, and reported.

Returns and Recall Management

Structured workflows for handling product returns, voluntary recalls, and regulatory actions — with clear chain-of-custody documentation at every step.

Secure Systems and Access

Access to systems, data, and facilities follows the principle of least privilege. User access is documented, reviewed, and controlled.

Audit Trails

System-generated records capture the who, what, and when of every critical business action — creating defensible documentation for internal and external review.

Regulatory Framework

The standards we operate against.

DSCSADrug Supply Chain Security Act

Product traceability, transaction documentation, and authorized trading partner requirements aligned with federal law.

FDAFDA Guidelines

Operating practices informed by FDA guidance for pharmaceutical wholesale distributors and 3PL providers.

StateState Licensing Requirements

Compliance with applicable state wholesale distributor licensing and pedigree requirements in each jurisdiction where we operate.

QAQuality Agreements

Written quality agreements with 3PL partners and, where applicable, suppliers — clearly defining responsibilities and performance standards.

Kalder Pharmaceuticals is developing its compliance infrastructure during the pre-launch period. Specific regulatory authorizations, state licenses, and operational claims will be updated on this site only after they have been verified and confirmed.

Questions about our compliance approach?

We welcome inquiries from qualified trading partners, logistics providers, and regulatory contacts.

Contact Our Team